A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Natural killer (NK) cells and gamma/delta T lymphocytes lyse tumor cells independently of MHC recognition.
• NK cells lack CD3/T cell receptor (TCR) molecules, and their cytotoxic receptors remain largely unidentified.
• Understanding NK cell surface molecules is crucial for elucidating their cytotoxic mechanisms.

Purpose of the Study:

• To develop monoclonal antibodies (mAbs) for identifying novel surface molecules on human NK cells.
• To characterize a newly identified molecule recognized by the BY55 mAb.
• To determine the role of BY55+ cells in NK cell-mediated cytotoxicity.

Main Methods:

• Development of monoclonal antibodies against the human NK leukemia cell line YT2C2.
• Immunophenotypic analysis using the BY55 mAb on various lymphocyte populations.
• Biochemical characterization of the BY55-reactive molecule.
• Functional assays to assess NK activity of BY55+ cells.

Main Results:

• Isolation of the BY55 mAb, recognizing a novel 80-kD protein on NK cells, gamma/delta+ T cells, and a subset of alpha/beta+ T lymphocytes.
• BY55 expression is downmodulated upon lymphocyte activation.
• BY55+ cells exhibit significant NK activity, identifying them as a unique subset of circulating lymphocytes mediating NK functions.
• The BY55 molecule is biochemically and phenotypically distinct from known lymphocyte surface structures.

Conclusions:

• The BY55 mAb defines a novel molecule on a unique subset of lymphocytes with potent NK activity.
• BY55+ cells represent a critical component of the innate immune system's cytotoxic response.
• Further characterization of the BY55 molecule may reveal new insights into NK cell recognition and activation pathways.